Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Corp Secrets being held at gunpoint tighter that a Gnatsarse

<< Previous

Bullboard Posts

Next >>

Comment by bealerton Oct 27, 2022 9:56am

158 Views

Post# 35052789

RE:RE:Corp Secrets being held at gunpoint tighter that a Gnatsarse

Regarding restructuring, Forehand, just the search for a new CEO and the other internal reviews that they supposedly are embarking on.

Their intentions might just be their attempt to give us a feel good moment, too, while they cook up another plan that they think they can sell shareholders.

GLTA

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale